Page last updated: 2024-08-17

quinoline and Multiple Sclerosis

quinoline has been researched along with Multiple Sclerosis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bertini, S; Bifulco, M; Carpi, S; Ciaglia, E; Di Marzo, V; Fogli, S; Gazzerro, P; Laezza, C; Ligresti, A; Lucchesi, V; Macchia, M; Malfitano, AM; Manera, C; Nieri, P; Parkkari, T; Pisanti, S; Saccomanni, G; Savinainen, JR	1

Other Studies

1 other study(ies) available for quinoline and Multiple Sclerosis

Article	Year
New quinolone- and 1,8-naphthyridine-3-carboxamides as selective CB2 receptor agonists with anticancer and immuno-modulatory activity. European journal of medicinal chemistry, 2015, Jun-05, Volume: 97 Topics: Amides; Anti-Inflammatory Agents; Antineoplastic Agents; Carboxylic Acids; Cell Line, Tumor; Cell Survival; Humans; Male; Molecular Structure; Multiple Sclerosis; Naphthyridines; Prostatic Neoplasms; Quinolines; Receptor, Cannabinoid, CB2; Reference Standards	2015

Article

Year

New quinolone- and 1,8-naphthyridine-3-carboxamides as selective CB2 receptor agonists with anticancer and immuno-modulatory activity.

European journal of medicinal chemistry, 2015, Jun-05, Volume: 97

Topics: Amides; Anti-Inflammatory Agents; Antineoplastic Agents; Carboxylic Acids; Cell Line, Tumor; Cell Survival; Humans; Male; Molecular Structure; Multiple Sclerosis; Naphthyridines; Prostatic Neoplasms; Quinolines; Receptor, Cannabinoid, CB2; Reference Standards

2015